Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

被引:91
|
作者
Severance E.G. [1 ]
Gressitt K.L. [1 ]
Stallings C.R. [2 ]
Katsafanas E. [2 ]
Schweinfurth L.A. [2 ]
Savage C.L. [2 ]
Adamos M.B. [2 ]
Sweeney K.M. [2 ]
Origoni A.E. [2 ]
Khushalani S. [2 ]
Leweke F.M. [3 ]
Dickerson F.B. [2 ]
Yolken R.H. [1 ]
机构
[1] Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
[2] Sheppard Pratt Health System, Stanley Research Program, Baltimore, MD
[3] Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim
来源
npj Schizophrenia | / 2卷 / 1期
关键词
D O I
10.1038/npjschz.2016.18
中图分类号
学科分类号
摘要
Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.
引用
收藏
相关论文
共 50 条
  • [21] Differentiating neurocognitive deficits in bipolar disorder from schizophrenia
    Ventura, J
    Altshuler, L
    van Gorp, W
    Theberge, D
    Mintz, J
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 111S - 111S
  • [22] LINGUISTIC PRODUCTION AND COMPREHENSION DEFICITS IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    Perlini, C.
    Marini, A.
    Fabbro, F.
    Garzitto, M.
    Cerruti, S.
    Marinelli, V.
    Rambaldelli, G.
    Ferro, A.
    Tomelleri, L.
    Bellani, M.
    Tansella, M.
    Brambilla, P.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [23] AUDITORY PROCESSING DEFICITS IN SCHIZOPHRENIA AND BIPOLAR DISORDER: DIAGNOSTIC SPECIFICITY, GENETIC CONTRIBUTION, AND BRAIN STRUCTURE CORRELATES
    VanMeerten, Nicolaas John
    Kang, Seung Suk
    Davenport, Nicholas
    Skorheim, M.
    Sponheim, Scott. R.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 42 - 43
  • [24] Executive deficits: A continuum schizophrenia-bipolar disorder or specific to schizophrenia?
    Ancin, Ines
    Cabranes, Jose A.
    Santos, Jose L.
    Sanchez-Morla, Eva
    Barabash, Ana
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1564 - 1571
  • [25] Schizophrenia-Like Cognitive Control Deficits in First Episode Bipolar Disorder with Psychotic Features
    Lesh, Tyler A.
    Minzenberg, Michael J.
    Yoon, Jong H.
    Ragland, J. Daniel
    Niendam, Tara A.
    Solomon, Marjorie
    Carter, Cameron S.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 86S - 86S
  • [26] Distinct Trajectories of Cognitive Control Deficits in First Episode Psychosis Patients with Schizophrenia and Bipolar Disorder
    Lesh, Tyler A.
    Niendam, Tara A.
    Minzenberg, Michael J.
    Yoon, Jong H.
    Ragland, J. Daniel
    Solomon, Marjorie
    Carter, Cameron S.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 92S - 92S
  • [27] Melatonin and Cognitive Deficits in Bipolar Disorder and Mild Cognitive Impairment
    Anderson, George
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (04) : 244 - 244
  • [28] Sensitivity and specificity of cognitive defects for bipolar disorder
    Glahn, David C.
    Bearden, Carrie E.
    Barguil, Marcela
    Barrett, Jennifer
    Soares, Jair C.
    Velligan, Dawn I.
    BIPOLAR DISORDERS, 2006, 8 : 2 - 3
  • [29] Executive functioning deficits in patients with schizophrenia, schizoaffective disorder, and bipolar disorder
    Balser, LA
    Wood, J
    Nimgaonkar, VL
    Pogue-Geile, MF
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 21S - 22S
  • [30] Specificity and Continuity of Schizophrenia and Bipolar Disorder: Relation to Biomarkers
    Yamada, Yuji
    Matsumoto, Madoka
    Iijima, Kazuki
    Sumiyoshi, Tomiki
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (02) : 191 - 200